Cardioneuroablation for Bradyarrhythmia

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Russia

Almazov National Medical Research Centre, Saint Petersburg

Sponsor

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

Collaborators

Meshalkin National Medical Research Center, Ministry of Health of Russian Federation, The Federal Centre of Cardiovascular Surgery, Russia

Enrollment target

~106 participants

Started

March 2024

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated March 2024